Cardiac Implants Market Top Leading Players with Strategies and Forecast 2027
Remote
Monitoring of Heart Diseases to Influence Global Cardiac Implants Market
Cardiac implants
are medical devices implanted in the heart for monitoring and maintenance of
normal functioning of the organ. They are used in the treatment of cardiac arrhythmia,
myocardial infarction, and others. The global cardiac implants market report by
Market Research Future (MRFR) looks at various developments in implants and the
breakthroughs for keeping cardiovascular diseases at bay for the period of 2018
to 2023 (forecast period).
Market Scope
The global cardiac
implants market can display a CAGR of 7.82% over the forecast period to
touch a value of USD 38,054.3 million by 2023. Major factors driving the market
growth are the large geriatric population and the prevalence of cardiovascular
diseases. The elderly populace is susceptible to heart conditions due to aging
and lead to coronary artery disease, atrial fibrillation, and others. According
to the Center for Disease Control & Prevention (CDC), 2.7 to 6.1 million in
the U.S. had atrial fibrillation in 2017.
But high costs
of these implants and risks of these injections can hamper the market growth.
Segmentation
The global
cardiac implants market has been segmented by device, indication, and end-user.
·
By device, it is segmented into
cardiac rhythm management devices, coronary stents, prosthetic heart valve
devices, ventricular assist devices, implantable loop recorder/implantable
cardiac monitor, and others.
·
By indication, the market has
been segmented into arrhythmias, myocardial ischemia, acute myocardial
infarction, heart failure, and others.
·
On the basis of end-user, the
market has been segmented into hospitals, cardiac
care centers, ambulatory centers & home care, academic institutes,
and others. The hospitals segment
accounted for a market value of USD 8,721.6 million in 2017.
Competition
Outlook
·
Edwards Lifesciences
Corporation,
·
LivaNova PLC,
·
B. Braun Melsungen AG,
·
Amg International,
·
Biotronik,
·
SynCardia Systems, Inc.,
·
Boston Scientific
Corporation,
·
Medtronic Plc,
·
Abbott, and
·
Terumo Corporation
are reputed
players of the global cardiac implants market.
Regional Analysis
The global
cardiac implants market, based on region, is divided into the Americas, Europe,
Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas had
dominated the market owing to the large prevalence of cardiovascular diseases
in North America and adoption of cardiac implantable devices in hospitals.
Development of wireless systems as well as a large healthcare expenditure for
the masses in North America can positively impact the regional cardiac implants
market growth. According to the American Heart Association, nearly 92.1 million
adults in the U.S. had suffered a cardiac attack.
Europe can
register a remarkable growth rate during the forecast period due to funds from
the government and rise of reimbursement schemes for heart patients. Italy, in
particular, had accounted for 9.9% share in 2017. Approval of new products by
regulatory bodies can be a victory for manufacturers making them easier to
bring it to market in the coming years. Recently, Abbott attained its approval
for its implantable cardioverter defibrillator and cardiac resynchronization
therapy defibrillator implants.
APAC can
showcase a stellar growth rate during the forecast period owing to the large
geriatric populace, cases of cardiovascular diseases, and rise of medical
tourism. Regulatory approval of devices for artificial control on a person’s
heartbeat can drive the regional cardiac implants market growth. High demand of
products for rhythm management and prevention for stroke will bode well
globally.
Lastly, the MEA
region is accountable for the lowest market share due to the slow growth of
economies.
Table
Content:
1
Report Prologue
2
Market Introduction
2.1 Definition 17
2.2 Scope Of Study 17
2.3 List Of Assumptions 17
2.4 Market Structure 18
3
Research Methodology
3.1 Research Process 20
3.2 Primary Research 21
3.3 Secondary Research 22
3.4 Market Size Estimation
23
3.5 Forecast Model 23
4
Market Dynamics
4.1 Overview 25
4.2 Drivers 26
4.2.1 Rising Prevalence Of
Cardiac Diseases 26
4.2.2 Increasing Geriatric
Population 26
4.3 Restraints 26
4.3.1 High Cost Of Cardiac
Implants 26
4.3.2 Risk Of Infection Due
To Cardiac Implants 27
4.4 Opportunities 27
4.4.1 Technological
Advancements In Cardiac Implants 27
TOC will be
continue..
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment